Clinical study for the assessment of security of candesartan in Parkinson?s disease population and its potential benefit in cognitive impairment associated to Parkinson?s disease. Clinical study for the assessment of security of candesartan in Parkinson?s disease population and i ...
A prospective, randomized, double-blind and placebo-controlled, parallel group, phase II study to compare the efficacy and safety of candesartan versus placebo on cognitive impairment associated with Parkinson?s disease. Exploratory study. A prospective, randomized, double-blind and placebo-controlled, parallel group, phase II study to co ...
Parkinson's Disease;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: Parapres
INSTITUT DE RECERCA HSCSP
NULL
Not Recruiting
Female: yes Male: yes
56
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...